FAQ for Sites during COVID-19

Date: April 2, 2020

Time: 12:00PM - 01:00PM

You must be registered to participate!

Please join us for an FAQ session led by David Vulcano, Vice President, Research Compliance & Integrity for HCA Healthcare, on how sites can ensure compliance through COVID-19.

Learning Objectives:

• Identify how COVID-19 response is affecting clinical trial sites.
  
• Discuss how clinical trial sites are responding to various COVID-19 related challenges.
• List the current enforcement discretions that the US government is allowing during this declared emergency.

Speakers:

• David Vulcano, Vice President, Research Compliance & Integrity for HCA Healthcare